Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995

被引:17
|
作者
Richardson, LC
Schulman, J
Sever, LE
Lee, NC
Coates, RJ
机构
[1] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA 30333 USA
[2] Battelle Mem Inst, Ctr Publ Hlth Res & Evaluat, Atlanta, GA USA
关键词
breast cancer treatment; cancer registries; poor; record linkages; screening program; uninsured; underinsured;
D O I
10.1023/A:1012252607421
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Little research has been conducted on the breast cancer treatment of low income, underserved women. This study was designed to describe initial treatment of breast cancer among low-income women diagnosed through federally funded screening programs in Detroit, Michigan, and the states of New Mexico and California; and to compare the treatment received by program women with early-stage breast cancer with that of all women diagnosed in those regions. Methods. Data from the three screening programs were linked with cancer registry data from the corresponding geographic areas. All women diagnosed between 1992 and 1995 through the state-based screening programs and all women contemporaneously diagnosed with breast cancer in the three regions were studied. Descriptive analyses were done of the proportion of women with breast cancer receiving treatment; the proportion of early-stage breast cancer (stage I or II) cases treated with breast-conserving surgery, and the proportion treated with mastectomy; and among women with breast-conserving surgery, the proportion receiving radiation therapy. Logistic regression models controlled for age and stage at diagnosis, race or ethnicity and geographic region. Results. Less than 2% of program women diagnosed with breast cancer received no treatment. More than two of five women with early-stage breast cancer underwent breast-conserving surgery, with 72% of these women receiving radiation therapy. Multivariate regression analysis revealed that women with stage IIA or IIB breast cancer had lower odds of undergoing breast-conserving surgery than women with stage I (0.51 [95% CI = 0.30-0.87] and 0.36 [95% CI = 0.19-0.70], respectively). Women over age 65 and those with incompletely staged cancer had the lowest odds for receiving radiation therapy after breast-conserving surgery (0.29 [95% CI = 0.09-0.99] and 0.14 [95% CI = 0.03-0.72], respectively). Women diagnosed through the screening programs had odds of undergoing breast-conserving surgery similar to those of all women in the regions (1.11 [95% CI = 0.89-1.39]). Conclusions. Treatment patterns for women diagnosed with early-stage breast cancer through three state-based screening programs appear to have been similar to those reported in the literature. In addition, their treatment appears to have been similar to that of other women during the same time period.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 50 条
  • [31] Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer
    Venturelli, Marta
    Guaitoli, Giorgia
    Omarini, Claudia
    Moscetti, Luca
    BREAST CANCER-TARGETS AND THERAPY, 2018, 10 : 39 - 49
  • [32] Comprehensive Diagnostic Program for Medically Underserved Women With Abnormal Breast Screening Evaluations in an Urban Population
    Palmieri, Frances M.
    DePeri, Elizabeth R.
    Mincey, Betty A.
    Smith, Judith A.
    Wen, Lonnie K.
    Chewar, Deborah M.
    Abaya, Reza
    Colon-Otero, Gerardo
    Perez, Edith A.
    MAYO CLINIC PROCEEDINGS, 2009, 84 (04) : 317 - 322
  • [33] Impact of screening mammography interval on stage and treatment in women diagnosed with breast cancer
    Ahn, Soojin
    Wooster, Margaux
    Valente, Christopher
    Pisapati, Kereeti
    Couri, Ronald
    Ru, Meng
    Moshier, Erin
    Schmidt, Hank
    Elisa, Port
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 281 - 282
  • [34] Breast Cancer Screening Among Medically Underserved Women in New Mexico: Potential for Lower Recall Rates with Digital Breast Tomosynthesis
    Manda-Mapalo, Martha T.
    Fine, Stephanie G.
    Safadi, Sarah
    Lee, Ji-Hyun
    Du, Ruofei
    Sussman, Andrew L.
    Mishra, Shiraz
    Selwyn, Reed G.
    Saline, Jennifer L.
    Hine, Wendy L.
    Brown-Glaberman, Ursa A.
    JOURNAL OF WOMENS HEALTH, 2020, 29 (12) : 1596 - 1601
  • [35] Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer
    Ro, Vicky
    McGuinness, Julia E.
    Guo, Boya
    Trivedi, Meghna S.
    Jones, Tarsha
    Chung, Wendy K.
    Rao, Roshni
    Levinson, Elana
    Koval, Carrie
    Russo, Donna
    Chilton, Ilana
    Kukafka, Rita
    Crew, Katherine D.
    JCO ONCOLOGY PRACTICE, 2022, 18 (04) : 287 - +
  • [36] Association between genetic testing for hereditary breast cancer and contralateral prophylactic mastectomy among young women diagnosed with early-stage breast cancer
    McGuinness, Julia E.
    Guo, Boya
    Trivedi, Meghna S.
    Jones, Tarsha
    Chung, Wendy K.
    Rao, Roshni
    Levinson, Elana
    Koval, Carrie
    Russo, Donna
    Chilton, Ilana
    CANCER RESEARCH, 2020, 80 (04)
  • [37] The impact of nodal micrometastasis on mortality among women with early-stage breast cancer
    Iqbal, Javaid
    Ginsburg, Ophira
    Giannakeas, Vasily
    Rochon, Paula A.
    Semple, John L.
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 103 - 115
  • [38] The impact of nodal micrometastasis on mortality among women with early-stage breast cancer
    Javaid Iqbal
    Ophira Ginsburg
    Vasily Giannakeas
    Paula A. Rochon
    John L. Semple
    Steven A. Narod
    Breast Cancer Research and Treatment, 2017, 161 : 103 - 115
  • [39] Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program
    Kenneth Elder
    Carolyn Nickson
    Melinda Pattanasri
    Samuel Cooke
    Dorothy Machalek
    Allison Rose
    Arlene Mou
    John Paxton Collins
    Allan Park
    Richard De Boer
    Claire Phillips
    Vicki Pridmore
    Helen Farrugia
    G. Bruce Mann
    Annals of Surgical Oncology, 2018, 25 : 2563 - 2572
  • [40] Usage and factors associated with adjuvant bisphosphonate therapy among postmenopausal women diagnosed with early-stage breast cancer.
    Panuganty, Veera Durga Sravanthi
    Lakkunarajah, Suganija
    Shanmuganathan, Sumugan
    Black, Morgan
    Nasreen, Sharifa
    Karp, Igor
    Vandenberg, Theodore A.
    Raphael, Jacques
    Fernandes, Ricardo
    Blanchette, Phillip S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)